Jelco Insulin Syringe Graduation Markings Recalled for Skew Defect
Smiths Medical recalls 1,432,200 Jelco insulin syringes with skewed graduation markings that could lead to incorrect dosing. Specific lot numbers are affected.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This FDA Class I recall requires a minimum severity score of 4. Although no illnesses or injuries have been reported, the defect—skewed graduation markings that could lead to incorrect insulin dosing—poses a significant risk of harm to diabetic patients dependent on accurate dose measurement.
Plain-English summary
Smiths Medical ASD Inc. is recalling 1,432,200 units of Jelco Hypodermic Needle-Pro Fixed Needle Insulin Syringes due to a manufacturing defect. The recall affects specific lot numbers of two models: 1.0 mL 28G x 1/2" (REF 4428-1) and 1.0 mL 29G x 1/2" (REF 4429-1).
The graduation markings on the syringe barrel are skewed approximately 20 degrees upward in affected units. These markings are critical for accurate insulin dosing; the skew may cause users to misread the intended dose and administer an incorrect amount of insulin.
The affected syringes were distributed worldwide, including throughout the United States, United Kingdom, and Spain. Specific affected lot numbers are identified in the FDA recall notice (Z-1798-2021).
Patients and healthcare providers should immediately discontinue use of recalled syringes. Anyone currently using a recalled syringe should consult their healthcare provider about alternative insulin delivery methods.
The recalled product
- Product
- JELCO HYPODERMIC NEEDLE-PRO FIXED NEEDLE INSULIN SYRINGE: a) 1.0mL 28G X 1/2" (0.33mm x 13mm), REF 4428-1 b) 1.0mL 29G X 1/2" (0.33mm x 13mm), REF 4429-1
- Manufacturer
- Smiths Medical ASD Inc.
- Category
- Medical Device — Insulin Syringe
- Affected units
- 1,432,200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- a) REF 4428-1
- Lot Numbers: 4046543 and 4062235 b) REF 4429-1
- Lot Numbers: 4031846
- 4031845
- 4040734
- 4043536
- 4046545
- 4046546
- 4062239
- 4062240
- 4062238
- 4062242
- 4014096
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Smiths Medical ASD Inc.
See all →- SevereCADD Solis VIP Ambulatory Infusion Pump Thermal Damage Recall
FDA (Devices) · 2025-05-14
- SevereCADD-Solis Infusion Pump Thermal Damage Risk Recall
FDA (Devices) · 2025-05-14
- CriticalCADD-Solis Ambulatory Infusion Pump False Alarm Malfunction
FDA (Devices) · 2025-05-14
- CriticalCADD Solis HSPCA Pump wireless connection alarm interruption recall
FDA (Devices) · 2025-05-14
- CriticalCADD-Solis VIP Ambulatory Infusion Pump False Occlusion Alarm Recall
FDA (Devices) · 2025-05-14
Same hazard · mis marking
See all →- HighKnee Patella Drills Recalled for Incorrect Diameter Markings
FDA (Devices) · 2023-04-19
Similar recalls
- HighSmiths Medical Recalls Insulin Syringes Due to Visible Particulate on Needles
FDA (Devices) · 2014-01-15
- HighSmiths Medical Recalls Insulin Syringes With Visible Particulate on Needles
FDA (Devices) · 2014-01-15
- HighSmiths Medical Insulin Syringes Recalled for Visible Particulate on Needles
FDA (Devices) · 2014-01-15
- ModerateSmith Medical JELCO Hypodermic Needle Recall for Incorrect Specifications
FDA (Devices) · 2019-06-12
- HighSmiths Medical Recalls Hypodermic Needles Due to Syringe Hub Defects
FDA (Devices) · 2017-07-12
- HighShinChang Recalls Disposable Insulin Syringes Due to Barrel Cracks
FDA (Devices) · 2018-09-26